Skip to main content
Clinical Trials/NCT03585140
NCT03585140CompletedNot Applicable

Effect of Adding a Diet With Low Glycemic Index and Load During 12 Weeks for the Treatment of Moderate Acne in Adults: a Randomized Clinical Trial

Centro Dermatológico Dr. Ladislao de la Pascua0 sites52 target enrollmentStarted: January 1, 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
52
Primary Endpoint
Count of inflammatory acne lesions

Study Overview

Brief Summary

Clinical trial to determine the effect of adding a diet with low glycemic index and load to adults for the treatment of moderate acne. Adult patients with acne where recruited in two groups, A and B. Group A received a normal diet according to their metabolic status and group B received a diet with low glycemic index and load. Outcomes were measured at week 12.

Detailed Description

Clinical trial to determine the effect of adding a diet with low glycemic index and load to adults for the treatment of moderate acne. Adult patients with acne where recruited in two groups, A and B. Both groups of treatment were treated with doxycycline 100 mg per day plus adapalene 0.1% gel daily for 12 weeks. During pharmacologic treatment, all patients had nutrition counseling monthly. Group A received a normal diet according to their metabolic status and group B received a diet with low glycemic index and load. At the end of the trial, the change in acne lesions count was analyzed and also their metabolic status. Quality of life was also measured.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Masking Description

Diet intervention was made by the nutrition specialist. Neither the principal investigator nor the outcome assessor were aware about the group of diet intervention.

Eligibility Criteria

Ages
18 Years to 25 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Having moderate inflammatory acne
  • 18 to 25 years old
  • Stable weight during the last 3 months

Exclusion Criteria

  • Previous or actual isotretinoin therapy
  • Antibiotic therapy or during the last 3 months
  • Therapy based on peelings, dermabrasion, laser or intense pulsed light during the last 6 months
  • Endocrine disorders
  • Drug and alcohol consumption during the last 6 months
  • Tabacco use during the last 6 months
  • Lactose intolerance
  • Have eating disorders or gastrointestinal disorders
  • Actual nutrition therapy
  • Have chronic diseases that requires pharmacologic therapy
  • Severe acne that requires isotretinoin therapy

Arms & Interventions

Normal Diet

Active Comparator

Participants will receive a normal diet according to their metabolic status.

Intervention: Normal diet (Other)

Normal Diet

Active Comparator

Participants will receive a normal diet according to their metabolic status.

Intervention: Adapalene 0.1% Gel (Drug)

Normal Diet

Active Comparator

Participants will receive a normal diet according to their metabolic status.

Intervention: Doxycycline (Drug)

Low glycemic diet

Experimental

Participants will receive a low-glycemic index and load diet according to their metabolic status. Milk and vitamin supplements will be eliminated from the diet.

Intervention: Low glycemic diet (Other)

Low glycemic diet

Experimental

Participants will receive a low-glycemic index and load diet according to their metabolic status. Milk and vitamin supplements will be eliminated from the diet.

Intervention: Adapalene 0.1% Gel (Drug)

Low glycemic diet

Experimental

Participants will receive a low-glycemic index and load diet according to their metabolic status. Milk and vitamin supplements will be eliminated from the diet.

Intervention: Doxycycline (Drug)

Outcomes

Primary Outcomes

Count of inflammatory acne lesions

Time Frame: 12 weeks

Number of papules and pustules

Secondary Outcomes

  • Count of non-inflammatory acne lesions(12 weeks)
  • Changes in quality of life(12 weeks)

Investigators

Sponsor
Centro Dermatológico Dr. Ladislao de la Pascua
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dra. Martha Alejandra Morales Sánchez

MD

Centro Dermatológico Dr. Ladislao de la Pascua

Similar Trials